ProfileGDS4718 / 203019_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 33% 32% 82% 33% 35% 72% 67% 33% 29% 34% 45% 29% 48% 64% 72% 48% 45% 52% 65% 40% 36% 48% 41% 43% 45% 58% 46% 56% 36% 58% 61% 73% 33% 33% 46% 57% 77% 35% 29% 80% 38% 58% 57% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6943633
GSM549102patient 115, normal, homogenized [OPG study]4.6502732
GSM549104patient 119, normal, homogenized [OPG study]8.1033582
GSM549108patient 138, normal, homogenized [OPG study]4.7336933
GSM549119patient 077, normal, homogenized [OPG study]4.7648235
GSM549133patient 032, cancer, homogenized [OPG study]7.0865572
GSM549139patient 042, cancer, homogenized [OPG study]6.6485467
GSM549099patient 107, normal, homogenized [OPG study]4.6973833
GSM549109patient 139, normal, homogenized [OPG study]4.5182129
GSM549110patient 046, normal, homogenized [OPG study]4.7315134
GSM549114patient 063, normal, homogenized [OPG study]5.213845
GSM549122patient 082, normal, homogenized [OPG study]4.5290929
GSM549134patient 033, cancer, homogenized [OPG study]5.3971948
GSM549136patient 036, cancer, homogenized [OPG study]6.4310664
GSM549140patient 044, cancer, homogenized [OPG study]7.0898572
GSM549111patient 047, normal, homogenized [OPG study]5.3860948
GSM549113patient 057, normal, homogenized [OPG study]5.1717645
GSM549132patient 031, cancer, homogenized [OPG study]5.6203952
GSM549137patient 038, cancer, homogenized [OPG study]6.5121865
GSM549142patient 047, cancer, homogenized [OPG study]5.1154340
GSM549100patient 110, normal, homogenized [OPG study]4.8161936
GSM549107patient 135, normal, homogenized [OPG study]5.3720148
GSM549115patient 068, normal, homogenized [OPG study]4.9661341
GSM549116patient 072, normal, homogenized [OPG study]5.1110343
GSM549120patient 078, normal, homogenized [OPG study]5.2420245
GSM549131patient 030, cancer, homogenized [OPG study]5.9787758
GSM549118patient 074, normal, homogenized [OPG study]5.2646846
GSM549129patient 027, cancer, homogenized [OPG study]5.898256
GSM549123patient 088, normal, homogenized [OPG study]4.772736
GSM549124patient 006, cancer, homogenized [OPG study]6.0173158
GSM549126patient 015, cancer, homogenized [OPG study]6.1534661
GSM549128patient 025, cancer, homogenized [OPG study]7.2199273
GSM549103patient 117, normal, homogenized [OPG study]4.7164333
GSM549117patient 073, normal, homogenized [OPG study]4.6570933
GSM549138patient 041, cancer, homogenized [OPG study]5.2964246
GSM549141patient 045, cancer, homogenized [OPG study]5.8829457
GSM549130patient 028, cancer, homogenized [OPG study]7.5093577
GSM549101patient 111, normal, homogenized [OPG study]4.8064535
GSM549105patient 128, normal, homogenized [OPG study]4.5307229
GSM549106patient 134, normal, homogenized [OPG study]8.0495580
GSM549112patient 048, normal, homogenized [OPG study]4.9081238
GSM549125patient 011, cancer, homogenized [OPG study]5.9803958
GSM549127patient 024, cancer, homogenized [OPG study]5.9838957
GSM549135patient 035, cancer, homogenized [OPG study]5.7706655